ScubaTx
Developer of a compact, modular organ preservation platform that combines precision hypothermic control and oxygen perfusion to extend ex vivo organ viability. The company focuses on device prototyping, preclinical validation, clinician partnerships (OPOs and transplant centres), data-enabled monitoring and AI readiness, and regulatory preparation for CE and FDA pathways.
Industries
Nr. of Employees
small (1-50)
Products
Advanced hypothermic organ preservation system (prototype ATC platform)
A compact, automated organ-preservation platform combining programmable hypothermic control and optional vascular oxygen perfusion to extend organ viability during transport.
ScubaTx Platform
A novel organ preservation platform that combines accurate, programmable hypothermic control with persufflation to deliver oxygen gas directly through the organ's vasculature during cold storage.
Advanced hypothermic organ preservation system (prototype ATC platform)
A compact, automated organ-preservation platform combining programmable hypothermic control and optional vascular oxygen perfusion to extend organ viability during transport.
ScubaTx Platform
A novel organ preservation platform that combines accurate, programmable hypothermic control with persufflation to deliver oxygen gas directly through the organ's vasculature during cold storage.
Services
Supply of prototype preservation systems to clinical collaborators for evaluation, preclinical testing, and workflow integration.
Execution of preclinical studies to evaluate preservation performance across organ models and refine device parameters prior to clinical translation.
Supply of prototype preservation systems to clinical collaborators for evaluation, preclinical testing, and workflow integration.
Execution of preclinical studies to evaluate preservation performance across organ models and refine device parameters prior to clinical translation.
Expertise Areas
- Organ preservation and transport
- Hypothermic preservation control
- Persufflation / oxygen perfusion techniques
- Medical device prototyping and preclinical validation
Key Technologies
- Hypothermic temperature-control systems
- Persufflation (vascular oxygen perfusion)
- Real-time telemetry and sensor integration
- AI / machine learning for viability prediction
News & Updates
Announcement referencing Innovate UK Biomedical Catalyst funding rounds that include projects described by the company.
Awarded grant to advance next-generation lung preservation technology combining advanced temperature control and persufflation in collaboration with a clinical professor.
Two prototype advanced temperature control organ preservation systems shipped to a collaborator in the USA for evaluation.
Company raised £1.5m including investment led by a life sciences fund and Innovate UK grant funding.
Award recognition in regional innovation competition.
Exhibited a fully integrated organ preservation and transport prototype at the British Transplant Society Annual Congress.
Announcement referencing Innovate UK Biomedical Catalyst funding rounds that include projects described by the company.
Awarded grant to advance next-generation lung preservation technology combining advanced temperature control and persufflation in collaboration with a clinical professor.
Two prototype advanced temperature control organ preservation systems shipped to a collaborator in the USA for evaluation.
Company raised £1.5m including investment led by a life sciences fund and Innovate UK grant funding.
Award recognition in regional innovation competition.
Exhibited a fully integrated organ preservation and transport prototype at the British Transplant Society Annual Congress.